{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:36:14Z","timestamp":1767857774903,"version":"3.49.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T00:00:00Z","timestamp":1316390400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022849","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T21:21:12Z","timestamp":1316467272000},"page":"e22849","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Tilda","family":"Barliya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilda","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tami","family":"Livnat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dov","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gad","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"32253","DOI":"10.1074\/jbc.271.50.32253","article-title":"Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its <italic>\u03b1<\/italic> subunit.","volume":"271","author":"LE Huang","year":"1996","journal-title":"J Biol Chem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-5793(99)01359-9","article-title":"Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction.","volume":"460","author":"E Minet","year":"1999","journal-title":"FEBS Lett"},{"key":"ref3","first-page":"2478","article-title":"Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.","volume":"62","author":"NJ Mabjeesh","year":"2002","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease.","volume":"1","author":"J Falkman","year":"1995","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/mgme.1998.2774","article-title":"The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase.","volume":"66","author":"HJ Ochel","year":"1999","journal-title":"Mol Genet Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2174\/187152008785914824","article-title":"Recent advances in Hsp90 inhibitors as antitumor agents.","volume":"8","author":"S Messaoudi","year":"2008","journal-title":"Anticancer Agents Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1073\/pnas.86.15.5773","article-title":"Actin polymerization induces a shape change in actin-containing vesicles.","volume":"86","author":"JD Cortese","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"PH Maxwell","year":"1999","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1a.","volume":"324","author":"S Zhao","year":"2009","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl hydroxylase.","volume":"7","author":"MA Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.","volume":"29","author":"GL Semenza","year":"2010","journal-title":"Oncogene"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ijc.20285","article-title":"Antimetastatic activity of the photodynamic agent hypericin in the dark.","volume":"111","author":"M Blank","year":"2004","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10456-005-3828-3","article-title":"Anti angiogenic activities of hypericin in vivo: potential for ophthalmologic applications.","volume":"8","author":"G Lavie","year":"2005","journal-title":"Angiogenesis"},{"key":"ref14","first-page":"8241","article-title":"Enhanced ubiquitinylation of Hsp90 as a potential mechanism of mitotic cell death in cancer cells induced with hypericin.","volume":"63","author":"M Blank","year":"2003","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"29936","DOI":"10.1074\/jbc.M204733200","article-title":"Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1a-degradative pathway.","volume":"277","author":"JS Isaacs","year":"2002","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4161\/cc.6.11.4296","article-title":"Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells.","volume":"6","author":"F Koga","year":"2007","journal-title":"Cell Cycle"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1101\/gad.1243304","article-title":"The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease.","volume":"18","author":"AJ Giaccia","year":"2004","journal-title":"Genes Dev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.","volume":"275","author":"ME Cockman","year":"2000","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.","volume":"2","author":"M Ohh","year":"2000","journal-title":"Nat Cell Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1021\/ja961783k","article-title":"Hypericin-induced cell photosensitization involves an intracellular pH decrease.","volume":"118","author":"F Sureau","year":"1996","journal-title":"J Am Chem Soc"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ccr.2007.08.004","article-title":"HIF-dependent antitumorigenic effect of antioxidants in vivo.","volume":"12","author":"P Gao","year":"2007","journal-title":"Cancer Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/0008-5472.CAN-05-0333","article-title":"Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1\u03b1 in cancer: role of free radical formation.","volume":"66","author":"M Quintero","year":"2006","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.","volume":"21","author":"E Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1379\/1466-1268(2003)8<37:IVRFVA>2.0.CO;2","article-title":"Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2\/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF.","volume":"8","author":"B Masson-Gadais","year":"2003","journal-title":"Cell Stress Chaperones"},{"key":"ref25","first-page":"RE21","article-title":"VEGF receptor signal transduction.","volume":"112","author":"T Matsumoto","year":"2001","journal-title":"Sci STKE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbamcr.2005.05.007","article-title":"Accumulation and nuclear import of HIF1 alpha during high and low oxygen concentration in skeletal muscle cells in primary culture.","volume":"1745","author":"HP Kubis","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/mol.62.5.975","article-title":"Reduction of Hypoxia-Induced Transcription through the Repression of Hypoxia-Inducible Factor-1\u03b1\/Aryl Hydrocarbon Receptor Nuclear Translocator DNA Binding by the 90-kDa Heat-Shock Protein Inhibitor Radicicol.","volume":"62","author":"E Hur","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"35194","DOI":"10.1074\/jbc.273.52.35194","article-title":"Hop as an adaptor in the heat shock protein 70 (Hsp70) and Hsp90 chaperone machinery.","volume":"273","author":"S Chen","year":"1998","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s12192-010-0211-0","article-title":"Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma.","volume":"15","author":"H Kubota","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1562\/0031-8655(2001)074<0120:ACAOHI>2.0.CO;2","article-title":"Anti-cancer activities of hypericin in the dark.","volume":"74","author":"M Blank","year":"2001","journal-title":"Photochem Photobiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.tcb.2005.09.003","article-title":"Modulating molecular chaperone Hsp90 functions through reversible acetylation.","volume":"15","author":"S Aoyagi","year":"2005","journal-title":"Trends Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"26729","DOI":"10.1074\/jbc.C500186200","article-title":"Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for anti leukemia activity of histone deacetylase inhibitors.","volume":"280","author":"F Bali","year":"2005","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.","volume":"18","author":"JJ Kovacs","year":"2005","journal-title":"Mol Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molcel.2007.01.001","article-title":"RACK1 competes with HSP90 for binding to HIF-1a and is required for O<sub>2<\/sub>-independent and HSP90 inhibitor-induced degradation of HIF-1\u03b1.","volume":"25","author":"YV Liu","year":"2007","journal-title":"Mol Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1101\/gad.14.16.1983","article-title":"HIF-1 and human disease: one highly involved factor.","volume":"14","author":"GL Semenza","year":"2000","journal-title":"Genes Dev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1751-1097.1993.tb04927.x","article-title":"Measurement of formal potentials for hypericin in dimethyl sulfoxide.","volume":"58","author":"J Redepenning","year":"1993","journal-title":"Photochem Photobiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"11861","DOI":"10.1021\/ja00153a007","article-title":"Electron acceptor properties of hypericin and its salts: an ESR\/ENDOR and electrochemical study.","volume":"117","author":"F Gerson","year":"1995","journal-title":"J Am Chem Soc"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/MCB.26.6.2019-2028.2006","article-title":"Histone deacetylase inhibitors induce VHL and ubiquitin independent proteasomal degradation of hypoxia-inducible factor 1\u03b1.","volume":"26","author":"X Kong","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1523\/JNEUROSCI.16-19-06089.1996","article-title":"Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells.","volume":"16","author":"K Yang","year":"1996","journal-title":"J Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1021\/bi00578a012","article-title":"Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ.","volume":"18","author":"JA Thomas","year":"1979","journal-title":"Biochemistry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0005-2728(84)90192-0","article-title":"Nigericin-induced transient changes in rat-liver mitochondria.","volume":"767","author":"M Zoratti","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1471-4159.1992.tb10124.x","article-title":"Intracellular pH on protein kinase C and ionomycin potentiation of isoproterenol-stimulated cyclic AMP and cyclic GMP production in rat pinealocytes.","volume":"59","author":"AK Ho","year":"1992","journal-title":"J Neurochem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/0008-5472.CAN-06-2968","article-title":"Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin.","volume":"67","author":"A Maloney","year":"2007","journal-title":"Cancer Res"},{"key":"ref44","article-title":"A Phase I\/II Study of Orally Administered Synthetic Hypericin for Treatment of Recurrent Malignant Gliomas.","author":"WT Couldwell","year":"2011","journal-title":"Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T01:14:30Z","timestamp":1712884470000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022849"}},"subtitle":[],"editor":[{"given":"Anil Kumar","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,9,19]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022849","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,19]]}}}